{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-025258","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2022-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.806763+00:00","generated_at":"2026-06-23T13:41:05.995107+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Elite Pharmaceuticals appoints Kirko Kirkov as Chief Commercial Officer effective Sept. 6, 2022","bullets":["Base salary $150k/year; increases to $275k after one year contingent on corporate goals.","Eligible for annual bonus up to 50% of salary (20% personal KPIs, 30% corporate performance).","Upon board approval, granted options to purchase 3,000,000 shares vesting over 3 years.","Kirkov brings 20+ years experience, most recently General Manager at Vertice Pharma.","New position to oversee sales and marketing of commercial products under Elite label."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-025258","json":"https://secwatch.observer/filing/0001493152-22-025258.json","markdown":"https://secwatch.observer/filing/0001493152-22-025258.md","text":"https://secwatch.observer/filing/0001493152-22-025258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/0001493152-22-025258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T13:41:05.995107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34c8f444b0","claim":"Kirko Kirkov was appointed as Chief Commercial Officer at ELITE PHARMACEUTICALS INC /NV/.","evidence_excerpt":"On September 5, 2022, Elite Pharmaceuticals, Inc., a Nevada corporation (the “Registrant”), entered into an employment agreement with Kirko Kirkov to serve as the Registrants’ Chief Commercial Officer effective September 6, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315222025258/0001493152-22-025258-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}